(Maryland advocates after testifying on behalf of House Bill 852 at the Maryland State House in Feb. 2020)
ZERO Cost to Prostate Cancer Screening
With a new effort, ZERO Cost to Prostate Cancer Screening, we are encouraging state governments to increase parity for prostate cancer screening.
Early detection continues to be the most effective means to saving lives from prostate cancer. However, few states offer screening without requiring cost-sharing on the behalf of patients. Our bold goal with this initiative is to expand prostate cancer screening mandates to half the country with 25 states by 2030.
The Promise of Parity and Meeting Unmet Patient Need
This new legislative effort aims to give prostate cancer parity to several other cancers which offer screenings with no attached co-pays or other cost-sharing fees. It’s urgent that we inspire legislation that will make prostate cancer screening free and accessible to all men. Early screening is the best preventative measure against the disease, which often presents no symptoms.
When the disease is detected early, survival rates are close to 100 percent. But when the disease is detected late, chances of survival fall to only 30 percent. The need for increased access to testing without sharing is critical because:
- The prevalence of prostate cancer means the disease needs parity with other cancers for affordable and accessible preventative screenings
- 99 Percent of patients survive the disease if detected early
- Fewer men are getting tested than ever before
- 2020 will see the highest number of prostate cancer deaths since the start of the millennia
- African American men are more than twice as likely to die because of lack of access to testing and care
Turning the Map Blue: Early Wins
New York: In January 2019, New York became the first state in the country to pass a law that supports full insurance coverage of the PSA (prostate-specific antigen) blood test, which helps determine prostate cancer risk. Learn more.
Maryland: In early 2020, ZERO and local advocates in Maryland helped pass a bill at the Maryland State House (shown right) that will remove prostate cancer screening cost-sharing for men ages 40-75 in the state. With prostate cancer being the most diagnosed male-only cancer in the state, this legislation has the power to catch disease early and save lives and prevent any financial barriers to care. The law went into effect in January 2021. Read op-eds from legislators and patients in support of this effort, and learn more.
Patient and caregiver stories make a difference! We need your voice to help improve access to testing without cost-sharing. By sharing your story, you’ll help:
- Provide context to strengthen screening and incidence data
- Give personal narratives that demonstrate the need to remove financial barriers to screening
- Be part of a passionate and powerful community of advocates
ZERO’s state-by-state strategy to zero out costs for prostate cancer screening and turn the U.S. map blue is now focused on California and Illinois with additional states to come. Sign up for advocacy alerts to get involved and join us to pass legislation in state governments nationwide that promotes accessibility and affordability of prostate cancer screenings.
Contact Ilana Ostrin, Director of Communications and Media Relations.